Your browser doesn't support javascript.
loading
Tankyrase-selective inhibitor STP1002 shows preclinical antitumour efficacy without on-target toxicity in the gastrointestinal tract.
Kim, Dong Young; Kwon, Young-Ju; Seo, Won Yong; Kim, Uk-Il; Ahn, Seohyun; Choi, Seong Mi; Bang, Hyung Tae; Kim, Kyungjin; Kim, Jae-Sung.
Afiliación
  • Kim DY; Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, Seoul, South Korea.
  • Kwon YJ; Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, Seoul, South Korea; Radiological and Medico-Oncological Sciences, University of Science and Technology, Seoul, South Korea.
  • Seo WY; ST Pharm Co., Ltd., Seoul, South Korea.
  • Kim UI; ST Pharm Co., Ltd., Seoul, South Korea.
  • Ahn S; ST Pharm Co., Ltd., Seoul, South Korea.
  • Choi SM; ST Pharm Co., Ltd., Seoul, South Korea.
  • Bang HT; ST Pharm Co., Ltd., Seoul, South Korea.
  • Kim K; ST Pharm Co., Ltd., Seoul, South Korea. Electronic address: kyungjin.kim@stpharm.co.kr.
  • Kim JS; Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, Seoul, South Korea; Radiological and Medico-Oncological Sciences, University of Science and Technology, Seoul, South Korea. Electronic address: jaesung@kirams.re.kr.
Eur J Cancer ; 173: 41-51, 2022 09.
Article en En | MEDLINE | ID: mdl-35849876

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Tanquirasas Límite: Animals / Humans Idioma: En Revista: Eur J Cancer Año: 2022 Tipo del documento: Article País de afiliación: Corea del Sur

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Tanquirasas Límite: Animals / Humans Idioma: En Revista: Eur J Cancer Año: 2022 Tipo del documento: Article País de afiliación: Corea del Sur